Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Bernstein upgrades McCormick to Outperform; '2023 should be much more tasty'

Published 01/27/2023, 07:37 AM
Updated 01/27/2023, 07:50 AM
© Reuters.  Bernstein upgrades McCormick (MKC) to Outperform; '2023 should be much more tasty'

By Michael Elkins

Bernstein upgraded McCormick & Co. (NYSE:MKC) to an Outperform rating (From market-perform) with a price target of $90.00 based on a recovery in fundamental performance over the course of 2023. The company remains the strongest in UBS' coverage over the longer term, and valuation looks relatively attractive, even given the tempered outlook for 2023.

McCormick reported 4Q revenues of $1,696 million, -4.0% below consensus estimates. The adjusted gross margin of 36.8% was -225bp below consensus and down -410bp YoY. Adjusted EBIT of $277.9m came in -15.3% below consensus and down -10.0% YoY, while EPS of $0.73 was a -13c miss and down -13.3% YoY.

Bernstein analysts wrote in a note, "Put simply, 2022 was an annus horribilis for MKC. The stock was by far the worst performer of the established U.S. packaged food names driven mainly by negative earnings revisions and as a result the company saw no benefit from the flight to safety that occurred in the wake of Russia's invasion of Ukraine. Of course this was in the wake of incredibly strong fundamental performance during the first couple of years of the pandemic as MKC was perfectly positioned as consumers hunkered down at home and learned how to cook from scratch."

4Q22 saw only 2.9% organic sales growth and gross margins fell by -410bp YOY as negative mix combined with plant closures and operational deleveraging to create a perfect storm. Going forward, the analysts expect $160m in cost savings in 2023 to combine with a catch-up in pricing vs. input costs to create steady sequential improvement in margin trends over the course of the year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company expects sales in 2023 to grow by 5-7% vs. consensus of 4.6%. However, adjusted operating income growth is expected to come in at 9-11% which implies 2023 adjusted EBIT of around -6.3% below consensus estimates at the midpoint of guidance. Adjusted EPS is expected to come in between $2.56-$2.61 vs. consensus of $2.90 - almost an 11% shortfall at the midpoint.

Shares of MKC are up 1.32% in pre-market trading on Friday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.